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Figure 1 │CHO-M1-mediated Gq/11-
activation: The bulkier allosteric moiety
naph disturbed Gq/11-mediated signaling
to a greater extent than phth.
(A) Agonist-induced Gq/11-activation in CHO-
M1 cells quantified by intracellular IP1.
(AI) Iperoxo was 100 fold more potent for M1-
mediated Gq/11-activation than the
endogenous agonist ACh. (AII, AIII) IP1
production was less compromised by
inclusion of a phth residue (AII) than a naph
moiety (AIII) as allosteric building block in
orthosteric-allosteric hybrid compounds.
Compounds
Results
Figure 3 │ CHO-M1-mediated activation of adenylyl cyclases can be facilitated by both Gs protein activation and Gq/11-mediated signaling.
(C) Agonist-induced increase in intracellular cAMP under control conditions, after permanent stimulation of Gs proteins (CTX), inhibition of Gi (PTX), and/or Gq/11 proteins (FR) [4]. All three muscarinic
full agonists acetylcholine (CI), iperoxo (CII), and carbachol (CIII) induced profound M1-mediated increase in intracellular cAMP, which could be masked by the Gs activator CTX. Interestingly, the Gq/11
inhibitor FR was able to decrease cAMP production for all three agonists (green curves) and this effect could be attenuated by additional blocking Gi proteins (blue curves). (CIV) Schematic
representation of the signaling repertoire of M1 mAChRs.
Figure 2 │CHO-M1-mediated Gs-activation:
(B) Agonist-induced Gs-activation in CHO-M1
cells quantified by intracellular cAMP.
(BI) In line with the findings for Gq/11 (A),
iperoxo was 100 fold more potent than ACh
for M1-mediated Gs-activation and (BII) cAMP
accumulation was less compromised by phth
than by (BIII) naph moieties. Interestingly,
iper-6-phth did not show any Gs activation
although this compound clearly activated
Gq/11 (AII).
G protein-coupled receptors (GPCRs) are cell surface receptors which, upon a conformational change in the receptor protein
induced by an extracellular stimulus, can transduce the signal onto intracellular adaptor proteins such as heterotrimeric G proteins
[1]. GPCR-induced cell signaling can be rather complex as several GPCRs may activate multiple different adaptor proteins and can
additionally be activated via distinct binding sites, i.e. the orthosteric transmitter binding site and other “allosteric” binding sites [2].
In the present work, we investigated the influence of an allosteric binding site on receptor activation of muscarinic acetylcholine
receptors (mAChRs). To this end, we employed the orthosteric full agonists acetylcholine (ACh) and iperoxo, as well as several
dualsteric compounds consisting of iperoxo linked to an allosteric phthalimide (phth) or naphthalimide (naph) moiety through alkyl
chains of different length, and investigated compound-induced activation of the human muscarinic M1 receptor. The M1 receptor
preferentially activates Gq/11 proteins, but can also promiscuously stimulate Gs proteins [3].
Here we show that the orthosteric full agonists ACh and iperoxo can lead to a M1 receptor-mediated increase in intracellular IP1
and cAMP which reflects Gq/11 and Gs protein activation, respectively. Previous studies with the muscarinic M2 receptor revealed
that the restriction of conformational flexibility by allosteric moieties that bind to the extracellular loops of the M2 receptor modulates
the signaling pattern of the promiscuous M2 receptor [2]. In line with this we present that different allosteric moieties, i.e. phth or
naph, in combination with various alkyl linker lengths can lead to a differential signaling pattern of the M1 receptor. For instance the
bulkier naph residue compromised M1-induced Gq/11 and Gs signaling to a greater extent than the smaller phth moiety.
Furthermore, we show that M1 receptor-mediated increase in intracellular cAMP is not only due to Gs activation but that also Gq/11-
induced elevation of intracellular Ca2+ contributes to the activation of adenylyl cyclases.
Chinese hamster ovary (CHO) cells stably transfected with the
human muscarinic M1 acetylcholine receptor (CHO-M1) were
cultured in Ham‘s nutrient mixture F-12 supplemented with
10% fetal calf serum, 100 U/ml penicillin, 100 µg/ml
streptomycin, 1 mM L-glutamine, and 0.2 mg/ml G418. The
cells were grown at 37°C and 5% CO2.
Second messenger assays were performed as described
previously [5]. Briefly, to quantify M1 receptor-mediated Gq/11-
activation, increase in intracellular IP1 was detected by using
the IP-One HTRF® assay kit (Cisbio, France).
Therefore100.000 cells/7 µl were seeded in 384 well microtiter
plates and stimulated with test compound for 30 min before IP1
was detected according to the manufacturer’s instructions.
To quantify M1 receptor-mediated Gs-activation, increase in
intracellular cAMP was detected using the cyclic AMP cell-
based assay kit (Cisbio, France). Cells were pretreated
overnight with either 50 ng/ml pertussis toxin (PTX), 100 ng/ml
cholera toxin (CTX), or both. 50.000 cells/5 µl were seeded in
384 well microtiter plates and incubated for two hours with or
without the Gq/11 inhibitor FR900359 (1 µM) [4]. Subsequent to
compound stimulation of 30 min, cAMP was detected
according to the manufacturers’ instructions.
Data analysis was performed using GraphPad Prism 5.03
(GraphPad Software, San Diego, CA). All experiments were
carried out in triplicates. Data are means ± s.e.m. from at least
two independent experiments and data points from individual
experiments were fitted to a four-parameter logistic equation
[6].
• M1 receptor activation was compromised by both allosteric volume and short linker length for Gs and Gq/11
signaling
• Gq/11-mediated signaling seemed to play an important role in adenylyl cyclase activation, since the intracellular
cAMP increase was significantly diminished when the Gq/11 protein was blocked
• A combination of various toxins gave first evidence that there is crosstalk between Gi and Gq/11 proteins, i.e.
M1 receptor-mediated Gi activation could only be detected when Gq/11 was blocked
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